Michele Morales

Synthetic biology first gained prominence through its impact on pharmaceuticals, where engineered microbes produce insulin, vaccines, and complex biologic drugs. Over the past decade, the same core capabilities—precise genetic design, scalable fermentation, and data-driven optimization—have matured and become cost-effective enough to address challenges far beyond medicine. As a result, synthetic biology is now expanding rapidly into materials science, targeting sectors such as textiles, construction, packaging, and electronics.This expansion is driven by a convergence of technological readiness, market demand for sustainability, and limitations of traditional material manufacturing.Technologies Driving the Widespread GrowthSeveral technical advances have lowered the barriers to applying synthetic biology…

Artificial intelligence is rapidly moving from experimental deployments to mission-critical systems across regulated industries such as finance, healthcare, energy, telecommunications, insurance, and pharmaceuticals. As AI increasingly influences decisions with legal, ethical, and societal impact, governance is no longer optional. It is becoming a foundational requirement driven by regulation, risk management, and public accountability.The Growing Influence of AI Across Critical Operational SettingsRegulated industries adopt AI to improve efficiency, accuracy, and scalability. Examples include credit scoring models in banking, diagnostic algorithms in healthcare, fraud detection in insurance, algorithmic trading in capital markets, and predictive maintenance in utilities. These systems often operate at…